The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 23, 2021

Filed:

Apr. 30, 2018
Applicants:

The Broad Institute, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambridge, MA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Aviv Regev, Cambridge, MA (US);

Ana Carrizosa Anderson, Brookline, MA (US);

Le Cong, Cambridge, MA (US);

Vijay K. Kuchroo, Chestnut Hill, MA (US);

Meromit Singer, Somerville, MA (US);

Chao Wang, Cambridge, MA (US);

Assignees:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/0783 (2010.01); A61K 35/17 (2015.01); A61K 39/00 (2006.01); G01N 33/50 (2006.01); A61K 45/06 (2006.01); C12N 15/10 (2006.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
C12N 5/0638 (2013.01); A61K 35/17 (2013.01); A61K 39/0011 (2013.01); A61K 45/06 (2013.01); C12N 15/1079 (2013.01); C12Q 1/6883 (2013.01); G01N 33/505 (2013.01); G01N 33/5023 (2013.01); G01N 33/5047 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/4703 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention provides markers, marker signatures and molecular targets that correlate with dysfunction of immune cells and are advantageously independent of the immune cell activation status. The present markers, marker signatures and molecular targets provide for new ways to evaluate and modulate immune responses. Specifically, GATA3 and/or FOXO1 modulation are provided for use as markers, marker signatures and molecular targets. Therapeutic methods are also provided to treat a patient in need thereof who would benefit from an increased immune response.


Find Patent Forward Citations

Loading…